Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 166-173, January 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herbrink, P.
Right arrow Articles by Warnaar, S. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herbrink, P.
Right arrow Articles by Warnaar, S. O.

Detection of Antibodies Cross-Reactive with Type C RNA Tumor Viral p30 Protein in Human Sera and Exudate Fluids1

Paul Herbrink2, John E. T. Moen, Johan Brouwer and Sven O. Warnaar

Department of Pathology, State University of Leiden, Wassenaarseweg 62, Leiden, The Netherlands

Human sera and human exudate fluids were surveyed for the presence of antibodies cross-reacting with a type C viral protein with a molecular weight of 30,000 (p30). Antibodies cross-reactive with type C viral p30 were concentrated by means of affinity chromatography using Sepharose beads to which disrupted Simian sarcoma virus or Rauscher murine leukemia virus p30 had been coupled. Eluates obtained from the affinity beads were tested for activity against Rauscher murine leukemia virus p30, Simian sarcoma virus p30, and endogenous feline virus RD-114 p30 by radioimmunoprecipitation. Of 57 eluates tested, 29 showed activity against type C viral p30. A number of eluates were also tested for anti-p30 activity by a visual microcytotoxicity assay. Of 11 eluates positive in the radioimmunoprecipitation assay, five were also positive in the microcytotoxicity assay.

1 This study was supported by the Queen Wilhelmina Foundation, the Dutch Organization for the Fight against Cancer.

2 To whom requests for reprints should be addressed.

Received 2/20/79. Accepted 10/ 5/79.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.